Phase
Condition
Benign Prostatic Hyperplasia (Enlarged Prostate)
Bladder Disorders
Prostate Disorders
Treatment
N/AClinical Study ID
Ages 50-85 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Symptomatic benign prostatic hyperplasia including patients with acute urinaryretention;
Peak urinary flow rate < 12 ml/sec;
American Urological Association (AUA) symptom score > 12.
Exclusion
Exclusion Criteria:
Previous open or transurethral prostatic surgery;
History of urethral stricture;
Failure to discontinue alpha-adrenergic blocking agents for at least 14 days prior tosurgery;
Failure to discontinue 5-alpha reductase inhibitor for at least 1 month prior tosurgery;
Patient interested in future fertility;
Patient with known neurogenic bladder dysfunction;
Untreated urinary tract infection;
American Society of Anesthesiologist (ASA) Class >III;
Patients requiring anticoagulation with Coumadin or Heparin;
Patient unable or unwilling to comply with follow-up schedule.
Study Design
Study Description
Connect with a study center
Alberta Urology Institute Research Centre
Edmonton, Alberta T5H 4B9
CanadaSite Not Available
Prostate Centre at Vancouver General Hospital
Vancouver, British Columbia V5Z 3J5
CanadaSite Not Available
Can-Med Clinical Research Inc
Victoria, British Columbia V8R 6T9
CanadaSite Not Available
Hamilton District Urology Associaton
Hamilton, Ontario L8N 1T8
CanadaSite Not Available
Centre for Advanced Urological Research at Queen's University
Kingston, Ontario K7L 3J7
CanadaSite Not Available
Urology Clinic & Prostate Centre, St. Joseph's Hospital, St. Joseph's Health Care London
London, Ontario N6A 4V2
CanadaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.